Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Endeavor Biomedicines, Inc.
ITM Solucin GmbH
National Cancer Institute (NCI)
Fudan University
National Cancer Institute (NCI)
European Organisation for Research and Treatment of Cancer - EORTC
M.D. Anderson Cancer Center
Neotropix